Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul C Tumeh

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2014
The future of cancer therapy: selecting patients likely to respond to PD1/L1 blockadeAntoni Ribas, Paul C Tumeh
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 31, 2008
PET imaging of cancer immunotherapyPaul C Tumeh, Caius G Radu, Antoni Ribas
BJR Case Reports|October 27, 2018
Enhanced skin toxicity with concurrent ipilimumab and radiation in vaginal/vulvar melanoma: a case report and literature reviewShane Mesko, Gottfried E Konecny, Paul C Tumeh, et al.
Cancer Biology & Therapy|March 28, 2007
Differentiation of vascular and non-vascular skin spectral signatures using in vivo hyperspectral radiometric imaging: implications for monitoring angiogenesisPaul C Tumeh, Jeremy M Lerner, David T Dicker, et al.
Seminars in Nuclear Medicine|February 10, 2007
Structural and functional imaging correlates for age-related changes in the brainPaul C Tumeh, Abass Alavi, Mohamed Houseni, et al.
Journal of the American Academy of Dermatology|June 11, 2011
Characteristic purpura of the ears, vasculitis, and neutropenia--a potential public health epidemic associated with levamisole-adulterated cocaineCatherine Chung, Paul C Tumeh, Ron Birnbaum, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2010
The impact of ex vivo clinical grade activation protocols on human T-cell phenotype and function for the generation of genetically modified cells for adoptive cell transfer therapyPaul C Tumeh, Richard C Koya, Thinle Chodon, et al.
Oncoimmunology|August 2, 2014
Distinct immunological mechanisms of CTLA-4 and PD-1 blockade revealed by analyzing TCR usage in blood lymphocytesLidia Robert, Christina Harview, Ryan Emerson, et al.
Cancer Immunology Research|January 1, 2017
Infiltration of CD8 T Cells and Expression of PD-1 and PD-L1 in Synovial SarcomaTheodore S Nowicki, Ryan Akiyama, Rong Rong Huang, et al.
Cancer Research|June 14, 2012
BRAF inhibitor vemurafenib improves the antitumor activity of adoptive cell immunotherapyRichard C Koya, Stephen Mok, Nicholas Otte, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2014
The future of cancer therapy: selecting patients likely to respond to PD1/L1 blockadeAntoni Ribas, Paul C Tumeh
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 31, 2008
PET imaging of cancer immunotherapyPaul C Tumeh, Caius G Radu, Antoni Ribas
BJR Case Reports|October 27, 2018
Enhanced skin toxicity with concurrent ipilimumab and radiation in vaginal/vulvar melanoma: a case report and literature reviewShane Mesko, Gottfried E Konecny, Paul C Tumeh, et al.
Cancer Biology & Therapy|March 28, 2007
Differentiation of vascular and non-vascular skin spectral signatures using in vivo hyperspectral radiometric imaging: implications for monitoring angiogenesisPaul C Tumeh, Jeremy M Lerner, David T Dicker, et al.
Seminars in Nuclear Medicine|February 10, 2007
Structural and functional imaging correlates for age-related changes in the brainPaul C Tumeh, Abass Alavi, Mohamed Houseni, et al.
Journal of the American Academy of Dermatology|June 11, 2011
Characteristic purpura of the ears, vasculitis, and neutropenia--a potential public health epidemic associated with levamisole-adulterated cocaineCatherine Chung, Paul C Tumeh, Ron Birnbaum, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2010
The impact of ex vivo clinical grade activation protocols on human T-cell phenotype and function for the generation of genetically modified cells for adoptive cell transfer therapyPaul C Tumeh, Richard C Koya, Thinle Chodon, et al.
Oncoimmunology|August 2, 2014
Distinct immunological mechanisms of CTLA-4 and PD-1 blockade revealed by analyzing TCR usage in blood lymphocytesLidia Robert, Christina Harview, Ryan Emerson, et al.
Cancer Immunology Research|January 1, 2017
Infiltration of CD8 T Cells and Expression of PD-1 and PD-L1 in Synovial SarcomaTheodore S Nowicki, Ryan Akiyama, Rong Rong Huang, et al.
Cancer Research|June 14, 2012
BRAF inhibitor vemurafenib improves the antitumor activity of adoptive cell immunotherapyRichard C Koya, Stephen Mok, Nicholas Otte, et al.
Pageof 2